Cancer is a leading cause of death worldwide. According to the World Health Organization (WHO), cancer deaths worldwide are projected to continue to rise to more than 11 million in 2030. The American Cancer Society estimates that in 2016 1.685 million new cases of cancer will be diagnosed. Nearly two-thirds of these patients will receive radiation therapy during their illness – most with the intent to cure the cancer. Advances in the applications, technologies and methodologies of radiation oncology continue to evolve rapidly and the delivery of radiation therapy has become more complex, making it imperative that the radiation oncology professional remain current in the state-of-the-art techniques. The American Society for Radiation Oncology is committed to providing educational programming that creates a forum for global collaboration on issues in radiation oncology to improve professional practice by increasing their level of knowledge, as required to improve competency and performance in the field of oncology.
At the conclusion of this activity, the learner will be able to:
The Annual Meeting program has been designed to narrow the competency gaps of patient/patient-centered care, medical knowledge, evidence-based practice, interpersonal skills and communication, practice-based learning and improvement, work in interdisciplinary teams, quality improvement, professionalism, professional standing and commitment to lifelong learning, eleven of the fifteen core competencies embraced by the American Board of Medical Specialties, Accreditation Council for Graduate Medical Education and the Institute of Medicine.
This continuing medical education activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation biologists, radiation physicists, dosimetrists, oncologists working in related specialties, radiation therapists, radiation oncology nurses, radiation oncology administrators, daignostic radiologists and all other health professionals involved in the field of radiation oncology.
ASTRO is an accredited provider of continuing medical education. Since our accreditation is important to us, we plan activities that are compliant with the ACCME and the content or format of CME activities and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias. Planning Committee members and speakers are required to disclose the existence of any financial or other relationship with the manufacturer(s) of any commercial product(s) or provider(s) of any commercial services discussed in an educational presentation.
Any conflicts of interest are resolved prior to participation. In addition to written disclosure, presenters will disclose any vested interest or their intention to discuss off-label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation and in accordance with the Accreditation Council for Continuing Medical Education standards and the Food and Drug Administration requirements.
In an effort to increase transparency and easy access to all disclosures, faculty, committee and planner disclosure information will be available online for the 2016 Annual Meeting. In addition, disclosure slides will be shown at the beginning of each session and in the Online Conference Planner and mobile app. Disclosure information will not be printed in paper versions of the meeting materials.
View the 2016 Annual Meeting Planner Disclosure of Relationships.
View the 2016 Abstract Reviewer Disclosure of Relationships.View the 2016 Faculty and Abstract Presenter Disclosure of Relationships.
ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.